Looking early, without predicting a lifetime

# Looking early, without predicting a lifetime OCTOBER 15, 2026 | LONGEVITY SPECIAL The bacteria in a baby's gut at 4 months old were linked to how the infant's visual brain was working months later. That is the finding of a study of 194 South African infants, published in mBio in 2025. It is early, observational work, and it makes no claim about lifelong brain health. The bigger idea, that the early gut microbiome shapes brain health across a lifetime, comes from a separate opinion piece in STAT by a program director at a research funder and an advocate. It remains a hypothesis. An infant's development offers a window into relationships that are only beginning to form. This study connects early gut microbes with later visual brain signals over months, a timescale that matters. The study is an observational, longitudinal study in people. It does not test a treatment, and it cannot prove cause and effect. Researchers followed infants from Gugulethu, a community in Cape Town, as part of the Khula Study. Stool samples and brain recordings were collected at up to three visits in the first 18 months of life. The team looked at microbial genes that code for enzymes. These enzymes handle brain-active compounds, according to the paper. The compounds included the neurotransmitters GABA and glutamate, the amino acid tryptophan, and short-chain fatty acids such as acetate and butyrate. The paper says short-chain fatty acids are involved in myelination, the insulation of nerve fibres. Stool samples were sequenced to read the microbes' genes. Brain development was measured with electroencephalography, or EEG. Infants watched a black-and-white checkerboard that flipped every half second. The EEG picked up the brain's response, called the visual-evoked potential. The authors say it reflects how well visual circuits are balanced and how well they are insulated. They pulled six features from it: the timing and size of three signal peaks. The main result concerns timing. According to the authors, microbial gene sets from around 4 months of age were strongly associated with the visual signal at around 9 to 14 months. These forward-looking links were more numerous than links between gut genes and brain signals measured at the same visit. The authors say this suggests early microbial metabolism may affect later neural plasticity and development. That wording is cautious, and it should stay that way. The study shows associations. It does not show that the microbes changed the brain. It measures the gut's genetic potential, not the chemicals actually made. It looks at one brain system, vision, in one community. The abstract does not say whether the findings apply to other groups or whether they relate to health outcomes later in life. The study matters to a longevity audience because of the question behind it. If early gut function does influence brain development, it would add a biological pathway to a story usually told through genes and upbringing. If it does not, the associations may reflect other shared influences, and gut-focused efforts would be off target. Either answer would change where research money and clinical attention go. The STAT opinion piece goes further than the study does. Holly Baines of Wellcome Leap, who directs its $50 million FORM program, and advocate George Vradenburg argue the early gut microbiome may be one way experience and environment shape the brain. They link it to possible effects reaching Alzheimer's disease decades later. They write that cesarean birth, antibiotic use, formula feeding and maternal BMI can contribute to a microbiome that develops off course. The mBio study did not test those exposures or dementia, and the op-ed does not discuss the mBio study. The STAT authors do hedge on their own claims. They write that on autism, causation is not established, and that on dementia the research is only now emerging. They also say they are not arguing against antibiotics, cesarean births or formula. Readers should not start, stop or change any medication, feeding or birth decision without talking to their clinician. The op-ed's central point is about care, not blame. In their words, "the mother's body and the infant's body are one system. We treat them as two." They call for large studies of the gut-brain axis across the life course. They also want biological markers that could flag vulnerability earlier than behavioral screening, which typically starts between 9 and 30 months in the United States, according to the piece. For now, the practical message for adults is modest. The idea that early gut microbes shape lifelong brain health remains a hypothesis. The infant data are suggestive, and the dementia link is more speculative still. What to watch next: larger and longer studies that follow infants beyond 18 months, test whether gut chemistry itself changes, and show whether any of this carries into later cognition. Longer follow-up could show whether the association persists and what it means. For now, the value is in a clearer developmental question, without assigning a child's future. Sources: mBio (2025), STAT (Opinion) ---